CIK 0001326110 · Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 431979754
- Phone
- (844) 696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,119,848
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,119,848. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-29 | Selecky Christobel Director | Sale 10b5-1 | −95,722 | $9.01 | $862K | 0 |
| 2026-06-29 | Selecky Christobel Director | Option exercise · Stock Option (right to buy) 10b5-1 | −32,173 | 35,764 | ||
| 2026-06-29 | Selecky Christobel Director | Option exercise · Stock Option (right to buy) 10b5-1 | −33,549 | 124,714 | ||
| 2026-06-29 | Selecky Christobel Director | Option exercise · Stock Option (right to buy) 10b5-1 | −30,000 | 132,786 | ||
| 2026-06-24 | Simon Barry J. Director | Sale 10b5-1 | −25,000 | $7.88 | $197K | 2,802,788 |
| 2026-06-09 | Selecky Christobel Director | Grant or award · Stock Option (right to buy) | +65,600 | 65,600 | ||
| 2026-06-09 | MAXWELL LINDA Director | Grant or award · Stock Option (right to buy) | +65,600 | 65,600 | ||
| 2026-06-09 | Cohen Cheryl Director | Grant or award · Stock Option (right to buy) | +65,600 | 65,600 | ||
| 2026-06-09 | BLASZYK MICHAEL D Director | Grant or award · Stock Option (right to buy) | +65,600 | 65,600 | ||
| 2026-06-09 | Wendel Bruce Director | Grant or award · Stock Option (right to buy) | +65,600 | 65,600 | ||
| 2026-06-09 | Clark Wesley Director | Grant or award · Stock Option (right to buy) | +65,600 | 65,600 | ||
| 2026-06-04 | Simon Barry J. Director | Sale 10b5-1 | −23,033 | $7.18 | $165K | 2,827,788 |
| 2026-03-31 | SOON-SHIONG PATRICK See remarks | Conversion | +4,606,596 | $5.43 | $25.0M | 251,018,873 |
| 2026-03-31 | SOON-SHIONG PATRICK See remarks | Conversion · Second Amended and Restated Convertible Promissory Note | −0 | |||
| 2026-02-24 | Simon Barry J. Director | Sale 10b5-1 | −75,000 | $12.01 | $901K | 2,850,821 |
| 2026-02-23 | Selecky Christobel Director | Option exercise 10b5-1 | +25,000 | $2.98 | $75K | 25,000 |
| 2026-02-23 | Selecky Christobel Director | Sale 10b5-1 | −25,000 | $10.00 | $250K | 0 |
| 2026-02-23 | Selecky Christobel Director | Option exercise · Stock Option (right to buy) 10b5-1 | −25,000 | 67,937 | ||
| 2026-02-23 | Simon Barry J. Director | Sale 10b5-1 | −165,000 | $10.25 | $1.7M | 2,925,821 |
| 2026-02-22 | Sachs David C. Chief Financial Officer | Option exercise | +40,650 | 320,825 |
Page 2 of 12 · 226 trades